# Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients

> **NCT01164397** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 268 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01164397
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** —
- **Final completion:** 2010-12
- **Target enrollment:** 268 (ACTUAL)
- **Last updated:** 2012-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164397, "Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01164397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*